A Case Report of Homozygous Familial Hypercholesterolemia Liver Transplantation
Homozygous familial hypercholesterolemia (HoFH) is a rare and serious autosomal genetic metabolic disease. Patients without intervention often die younger than 30 years old from early atherosclerotic cardiovascular disease (ASCVD)incurred by extremely high levels of low-density lipoprotein cholester...
Main Authors: | CHEN Peipei, TIAN Zhuang, CHEN Wei, MA Mingsheng, LIU Xin, QIN Yan, XU Haifeng, ZHU Zhijun, ZHANG Shuyang |
---|---|
Format: | Article |
Language: | zho |
Published: |
Editorial Office of Journal of Rare Diseases
2023-01-01
|
Series: | 罕见病研究 |
Subjects: | |
Online Access: | https://jrd.chard.org.cn/article/doi/10.12376/j.issn.2097-0501.2023.01.008 |
Similar Items
-
Perioperative Management and Clinical Outcomes of Liver Transplantation for Children with Homozygous Familial Hypercholesterolemia
by: Huan-Rong Qiu, et al.
Published: (2022-10-01) -
Contemporary Homozygous Familial Hypercholesterolemia in the United States: Insights From the CASCADE FH Registry
by: Marina Cuchel, et al.
Published: (2023-05-01) -
Familial homozygous hypercholesterolemia with arcus cornea and xanthomas: A rare but serious entity
by: Amal Chamli, et al.
Published: (2023-03-01) -
Clinical Evaluation Of Evolocumab For The Treatment Of Homozygous Familial Hypercholesterolemia In Chinese Patients
by: Huang CC, et al.
Published: (2019-10-01) -
Real‐World Effectiveness of PCSK9 Inhibitors in Reducing LDL‐C in Patients With Familial Hypercholesterolemia in Italy: A Retrospective Cohort Study Based on the AIFA Monitoring Registries
by: Marcello Arca, et al.
Published: (2023-11-01)